Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 04-2010 | 01-2010 | 10-2009 | 07-2009 | 04-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,720 | -12,142 | -1,814 | -23,564 | -18,285 |
| Depreciation Amortization | 3,224 | 2,187 | 943 | 3,462 | 2,351 |
| Income taxes - deferred | -136 | -126 | -119 | N/A | -237 |
| Accounts receivable | -1,574 | -913 | -2,078 | -1,409 | -2 |
| Accounts payable and accrued liabilities | 336 | 621 | -99 | -571 | -1,836 |
| Other Working Capital | -2,433 | 4,534 | -3,282 | 1,197 | 1,257 |
| Other Operating Activity | 4,062 | 2,104 | 3,601 | 9,408 | 8,015 |
| Operating Cash Flow | $-13,241 | $-3,735 | $-2,848 | $-11,477 | $-8,737 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,501 | 6,997 | 2,998 | -43,306 | -47,703 |
| PPE Investments | -2,569 | -2,044 | -1,128 | -2,709 | -2,156 |
| Net Acquisitions | N/A | N/A | N/A | -14,541 | -12,738 |
| Other Investing Activity | 25 | 9 | 49 | 384 | 368 |
| Investing Cash Flow | $14,957 | $4,962 | $1,919 | $-60,172 | $-62,229 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 348 | 348 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $348 | $348 |
| Exchange Rate Effect | -48 | 1 | 74 | -92 | -150 |
| Beginning Cash Position | 6,929 | 6,929 | 6,929 | 78,322 | 78,322 |
| End Cash Position | 8,597 | 8,157 | 6,074 | 6,929 | 7,554 |
| Net Cash Flow | $1,668 | $1,228 | $-855 | $-71,393 | $-70,768 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,241 | -3,735 | -2,848 | -11,477 | -8,737 |
| Capital Expenditure | -2,569 | -2,044 | -1,128 | -2,709 | -2,156 |
| Free Cash Flow | -15,810 | -5,779 | -3,976 | -14,186 | -10,893 |